Edwards Lifesciences
EW · NYSE
Bulios Fair Price
$63.45
27.3% downside
Current Price
$87.26
According to Bulios Fair Price, EW is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Edwards Lifesciences Corporation is an American company headquartered in Irvine, California. It specializes in the development, manufacturing, and sale of medical devices and technologies focused on the treatment of cardiovascular diseases. Their main products include innovative devices for surgical and interventional treatments of the heart and blood vessels, including valve replacements, surgical revascularization devices, monitoring systems, and more. Edwards Lifesciences Corporation is known for its advanced technologies and innovative products that contribute to the treatment of patients with cardiovascular diseases and improve their quality of life. The company has a global presence and is recognized as a leader in the field of cardiovascular medical technologies. Shares of Edwards Lifesciences Corporation are publicly traded on the NASDAQ stock exchange.
Sector
Healthcare
Industry
Medical - Devices
CEO
Bernard J. Zovighian
Employees
16,000
Headquarters
Irvine
Upcoming events
Earnings
Upcoming earnings report